Revista Médica-01.indd - Hospital General de Culiacán

Accesado 04/03/2007.
13. http://www.ssa-sin.gob.mx/Estadisticas/Morbilidad/notificacion.htm (SUIVE/DGE/SSA). Accesado 04/03/2007.
14. Datos del Laboratorio Estatal de Salud Publica de Sinaloa.
15. Datos de la Dirección de Epidemiología. Servicios de Salud de Sinaloa.
16. Burke D, y cols. A prospective study of Dengue infections in Bangkok. Am J Trop Med Hyg 1988;38:172-80.
17. Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control. PAHO Scientific Publication, No 548. 1994
18. Rigau-Perez J, y Asociacion de Epidemiologos de Puerto Rico. Manifestaciones clínicas del dengue hemorrágico en Puerto Rico, 1990-1991.
Rev Panam Salud Publica. 1997;1(6):435-443.
19. Gonzalez-Cortinas M, Vidal-Gonzalez D, Cerero-Cordero, J y cols. Dengue hemorrágico: Estudio clínico de 200 pacientes. Rev cubana med.
1999;38(1):13-18.
20. Rivas-Llamas R, Chaín-Castro R, Murillo-Llanes J, Ramírez-Zepeda M, Gadea-Alvarez T, López-López E. Manifestaciones hemorrágicas en el
dengue. Rev Biomed 2005; 16:87-94.
21. Gubler D. The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy. Rev
Panam Salud Publica. 2005;17(4):221-224.
22. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, control. 2d ed. Geneva: World Health Organization, 1997
23. Zavala-Velázquez J, Vado-Solís I, Rodríguez-Félix M, Rodríguez-Angulo E, Barrera-Pérez M, Guzmán-Marín E. Leptospirosis anictérica en un
brote epidémico de dengue en la Península de Yucatán.Rev Biomed 1998; 9:78-83.
24. Wilson M, Chen L. Dengue in the Americas. Dengue Bulletin. 2002;26:44-61.
25. Halsted S. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476-481.
26. Vaughn D, Green S, Kalayanarooj S, y cols. Dengue in the Early Febrile Phase: Viremia and Antibody Responses. The Journal of Infectious
Diseases 1997;176:322–30.
27. Vaughn D, Green S, Kalayanarooj S, y cols. Early Clinical and Laboratory Indicators of Acute Dengue Illness. The Journal of Infectious Diseases
1997;176:313–21.
28. Rosen L. The pathogenesis of dengue haemorrhagic fever. A critical appraisal of current hypotheses. S Afr Med J. 1986;11;Suppl:40-2.
29. Vaughn D, Green S, Kalayanarooj S, y cols. Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and
Disease Severity. The Journal of Infectious Diseases. 1999;179:755-762
30. Vaughn D, Green S, Kalayanarooj S, y cols. Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
The Journal of Infectious Diseases. 2000;181:2-9.
31. Pei-Yun S, Jyh-Hsiung. Current Advances in Dengue Diagnosis. Clin Diagn Lab Immunol. 2004;11(4):642-650.
32. Guzmán M, Kouri G. Advances in Dengue Diagnosis. Clin Diagn Lab Immunol. 1996;3(6):621-627.
33. Wali JP, Biswas A, Aggarwal P, Wig N, Handa R. Validity of tourniquet test in dengue haemorrhagic fever. J Assoc Physicians India.
1999;47(2):203-4.
34. Schilling S, Ludolfs D, Van An L, Schmitz H. Laboratory diagnosis of primary and secondary dengue infection.J Clin Virol. 2004 Nov;31(3):179-84.
35. Kuno G., Gomez I., Gubler D.J. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 1991;33:101-13.
36. Dittmar D., Cleary J., Castro A. Immunoglobulin G- and M- specific enzyme-linked immunosorbent assay for detection of dengue antibodies. J
Clin Microbiol 1979;9:498-502.
37. Henchal E.A., Narupitis R., Feighny R., et al. Detection of dengue virus RNA using nucleic acid hybridization. J Virol Methods 1987;15:187-200.
38. Deubel V., Laille M., Hugnot J.P., et al. Identification of dengue sequences by genomic amplification: rapid diagnosis of dengue virus serotypes in
peripheral blood. J Virol Methods 1990;30:41-54.
39. Kneen R, Wills B, Phuong T, Thien C, Nga T, Simpson J, Solomon T, White N, Farrar J, y cols. Acute Management of Dengue Shock Syndrome:
A Randomized Double-Blind Comparison of 4 Intravenous Fluid Regimens in the First Hour. Clinical Infectious Diseases 2001;32:204-213.
40. Wills B, Kneen R, Phuong T, Thien C, Nga T, Simpson J, Solomon T, White N, Farrar J, y cols Comparison of Three Fluid Solutions for Resuscitation
in Dengue Shock Syndrome. 2005;353(9):877-889.
41. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of High-Dose Methylprednisolone in Established Dengue Shock Syndrome:
A Placebo-Controlled, Double-Blind Study. Pediatrics. 1993; 92(1):111-115.
42. Chairulfatah A, Setiabudi D, Agoes R, Colebunders R. Thrombocytopenia and Platelet Transfusions in Dengue Haemorrhagic Fever and Dengue
Shock Syndrome. Dengue Bulletin. 2003;27:138-143.
Enviar sobretiros a Dr. Israel Diarte A.
Calle Cerro de las Cumbres 583 Colonia Colinas del Rey, C.P. 80177, Culiacán, Sinaloa.
Teléfono: 761 31 07
E-mail: i.diarte.a@gmail.com
Archivos de Salud de Sinaloa
30
Archivos de Salud de Sinaloa
31